Novavax

Novavax

Late-stage biotechnology company focused on the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

HQ location
Gaithersburg, United States
Launch date
Market cap
$1.0b
Enterprise value
$530m
Share price
$6.30 NVAX
Recent deals
Authorizing premium user...